Open AccessBusulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience
Author(s) -
Kebede H. Begna,
A Abdelatif,
Susan M. Schwager,
Curtis A. Hanson,
Animesh Pardanani,
Ayalew Tefferi
Publication year - 2016
Publication title -
blood cancer journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.607
H-Index - 51
ISSN - 2044-5385
DOI - 10.1038/bcj.2016.34
Subject(s) - busulfan , chronic myelogenous leukemia , medicine , polycythemia vera , essential thrombocythemia , imatinib mesylate , myelofibrosis , oncology , myeloproliferative disorders , tyrosine kinase inhibitor , chlorambucil , leukemia , pharmacology , imatinib , chemotherapy , hematopoietic stem cell transplantation , bone marrow , transplantation , myeloid leukemia , cyclophosphamide , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom